Liquidia price target lowered to $23 from $24 at BofA
PremiumThe FlyLiquidia price target lowered to $23 from $24 at BofA
1M ago
Liquidia price target lowered to $29 from $32 at H.C. Wainwright
Premium
The Fly
Liquidia price target lowered to $29 from $32 at H.C. Wainwright
1M ago
United Therapeutics price target raised to $380 from $350 at Wells Fargo
Premium
The Fly
United Therapeutics price target raised to $380 from $350 at Wells Fargo
1M ago
Raymond James starts Liquidia with Outperform into potential approval
PremiumThe FlyRaymond James starts Liquidia with Outperform into potential approval
1M ago
Court filing in United/FDA case may portend decision on Yutrepia, says Needham
Premium
The Fly
Court filing in United/FDA case may portend decision on Yutrepia, says Needham
1M ago
United Therapeutics price target lowered to $280 from $303 at BofA
Premium
The Fly
United Therapeutics price target lowered to $280 from $303 at BofA
2M ago
Truist biotech analyst holds an analyst/industry conference call
PremiumThe FlyTruist biotech analyst holds an analyst/industry conference call
2M ago
United Therapeutics price target raised to $350 from $270 at TD Cowen
Premium
The Fly
United Therapeutics price target raised to $350 from $270 at TD Cowen
2M ago
United Therapeutics downgraded to Equal Weight from Overweight at Morgan Stanley
Premium
The Fly
United Therapeutics downgraded to Equal Weight from Overweight at Morgan Stanley
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100